Jan Lindebjerg

Activities

Activities per year 2007 2007 2010 2016 2017 2020

• 6 Talks and presentations in private or public companies
• 2 Membership of commitees, commissions, boards, councils, associations, organisations, or similar
• 1 Conference organisation or participation
• 1 External examination
• 1 More
  • 1 Conference presentations

Activities per year

Search results

• ESGAR 2020

  Emilie Erbs (Participant), Søren Rafael Rafaelsen (Participant), Jan Lindebjerg (Participant), Lars Henrik Jensen (Participant) & Torben Frøstrup Hansen (Participant)

  20. May 2020

  Activity: Attending an event › Conference organisation or participation

• Korttidsresultater, præparatkvalitet og foreløbige overlevelsesdata i en serie af åbne, udvidede højresidige hemikolektomier med CME kirurgi for koloncancer. Et single-center studie af en prospektiv gruppe af selekterede patienter, udeladende de ældste og mest skrøbelige patienter.

  Lars Bundgaard (Lecturer), Jesper Andersen (Other), Jan Lindebjerg (Other), Erik Frostberg (Other) & Hans Bjarke Rahr (Other)

  1. Nov 2019

  Activity: Talks and presentations › Conference presentations

• DACG (External organisation)

  Jan Lindebjerg (Chairman)

  2017

  Activity: Membership › Membership of commitees, commissions, boards, councils, associations, organisations, or similar

• DCCG's Videnskabelige Udvalg (External organisation)

  Jan Lindebjerg (Chairman)

  2017

  Activity: Membership › Membership of commitees, commissions, boards, councils, associations, organisations, or similar

• H-kursus for onkologer

  Jan Lindebjerg (Supervisor)

  2017

  Activity: Examination and external supervision › Examination

• Next generation sequencing applied on colon and lung cancer samples- new opportunities

  Jan Lindebjerg (Lecturer)

  10. Mar 2016 → 12. Mar 2016

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Gastrointestinal patologi

  Jan Lindebjerg (Lecturer)

  2016

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Consecutive endoscopies with biopsy taken during long-term chemoradiation for advanced rectal cancer can predict complete response

  Jan Lindebjerg (Speaker)

  28. Mar 2010 → 30. Mar 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• The prognostic value of genetic variations in the vascular endothelial growth factor A gene in colorectal cancer

  Jan Lindebjerg (Speaker)

  28. Mar 2010 → 30. Mar 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Does radiotherapy have an effect on the accuracy of TRUS in patients with rectal cancer?

  Jan Lindebjerg (Speaker)

  9. Mar 2007 → 13. Mar 2007

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Gene expression of MLH1 related to microsatellite instability, immuno-histochemistry, and promoter hypermethylation in colorectal cancer

  Jan Lindebjerg (Speaker)

  2007

  Activity: Talks and presentations › Talks and presentations in private or public companies